Log in to save to my catalogue

Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensit...

Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensit...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_138e7105345a42ddac1dc39908b0c2b5

Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score‐matched analysis

About this item

Full title

Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score‐matched analysis

Publisher

United States: John Wiley & Sons, Inc

Journal title

Cancer medicine (Malden, MA), 2019-12, Vol.8 (18), p.7567-7576

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
Erythropoiesis‐stimulating agents effectively improve the hemoglobin levels in a fraction of anemic patients with myelodysplastic syndromes (MDS). Higher doses (HD) of recombinant human erythropoietin (rhEPO) have been proposed to overcome suboptimal response rates observed in MDS patients treated with lower “standard doses” (SD) of r...

Alternative Titles

Full title

Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score‐matched analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_138e7105345a42ddac1dc39908b0c2b5

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_138e7105345a42ddac1dc39908b0c2b5

Other Identifiers

ISSN

2045-7634

E-ISSN

2045-7634

DOI

10.1002/cam4.2638

How to access this item